CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash Flows From Operating Activities
Net loss	$ (18,123,516)	$ (4,665,522)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	258,189	307,262
Amortization of debt discount and deferred financing costs	540,648	8,843
Fair value of stock options and warrants issued to employees, directors and consultants	509,966	488,818
Change in fair value of derivative instruments	(20,845)	(27,712)
Loss on disposal of Cryogenic shippers	5,884	6,382
Debt conversion expense	13,713,767	0
Changes in operating assets and liabilities:
Accounts receivable	(418,590)	(55,013)
Inventories	9,204	(3,705)
Other current assets	(22,898)	8,940
Accounts payable and accrued expenses	129,415	301,425
Accrued compensation and related expenses	174,006	(67,531)
Accrued interest	85,364	19,625
Net cash used in operating activities	(3,159,406)	(3,678,188)
Cash Flows From Investing Activities
Purchases of property and equipment	(139,541)	(71,165)
Net cash used in investing activities	(139,541)	(71,165)
Cash Flows From Financing Activities
Proceeds from issuance of convertible debt	3,206,301	0
Repayments of convertible debt	0	(82,800)
Payments of offering and deferred financing costs	(358,489)	(128,275)
Repayments of related party notes payable	(72,000)	(72,000)
Proceeds from exercise of stock options and warrants	180,001	0
Net cash provided by (used in) financing activities	2,955,813	(283,075)
Net change in cash and cash equivalents	(343,134)	(4,032,428)
Cash and cash equivalents, beginning of period	563,104	4,617,535
Cash and cash equivalents, end of period	219,970	585,107
Cash paid during the period for:
Interest	0	15,676
Income taxes	0	1,600
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Release of restricted cash for repayment of convertible debentures payable	0	251,368
Offering costs in connection with equity financing included in accounts payable	0	53,747
Estimated relative fair value of warrants issued in connection with convertible debentures payable	255,452	0
Conversion of Bridge Notes payable and accrued interest into shares of common stock and warrants	$ 4,127,202	$ 0